A 12-months Multi-national, Multi-centre, Double Blind, Randomised, Parallel Safety and Efficacy Comparison of Insulin Detemir Produced by the Current Process and Insulin Detemir Produced by the NN729 Process in Subjects With Type 1 Diabetes on a Basal-bolus Regimen With Insulin Aspart as the Bolus Insulin
Каталог · ЕАЭС
Клинические исследования и проекты
Ново Нордиск А/С · найдено 123
123 исследования
Завершено
Фаза III
Россия
insulin detemir; insulin aspart; insulin detemir · Ново Нордиск А/С
Завершено
Фаза III
Россия
insulin degludec/insulin aspart; insulin detemir; insulin aspart; insulin aspart · Ново Нордиск А/С
NN5401-3594: A 26-week, Open-labelled, Two-arm, Parallel, Randomised Trial Comparing Efficacy and Safety of NN5401 Once Daily Plus Insulin Aspart vs. Basal-bolus Treatment With Insulin Detemir Plus Insulin Aspart in Subjects With Type 1 Diabetes / NN5401-3645: An Extension Trial Comparing Safety and Efficacy of NN5401 Plus Meal-time Insulin Aspart for the Remaining Meals With Insulin Detemir Plus Meal-time Insulin Aspart in Type 1 Diabetes (BOOST™: T1)
Завершено
Фаза III
Россия
biphasic insulin aspart · Ново Нордиск А/С
Effect of Biphasic Insulin Aspart 30 on Glycaemic Control in Subjects With Type 2 Diabetes